INACTIVE
Full-Time
Vice President
Posted on 1/12/2023
Clinical stage genome editing for disease treatment
Biotechnology
Expert
Cambridge, MA, USA
Requirements
- Previous experience in collection and handling metrics related to PV operations
- Strong relationship building skills, with ability to interact effectively in a multifunctional and multicultural team setting
- Excellent written and verbal communication skills to a variety of levels and teams, internally and externally
- Demonstrated persuasion, influencing and negotiation skills
- Ability to operate objectively and independently as a leader and as a member of matrix teams, as required
- Effective team player, with proven ability to effectively lead projects and teams to successful conclusion
- Hands on and motivated leader to drive the risk management and the clinical programs
- Demonstrated ability to influence across a matrix structure, and to collaborate in a cross-functional environment
- Highly organized and proficient in working in matrix team to support business and clinical program needs
- Provides motivational leadership to the organization and improve its performance
- Strong problem-solver and business acumen
- Strong interpersonal, verbal and written communication skills organizational and workload planning skills along with the ability to manage multiple different projects simultaneously
- Demonstrated ability as a line function manager
- Exposure to and management of significant accelerations and challenges in clinical programs
- MD or MD PHD with 15 years or more in industry with majority in Pharmacovigilance with prior experience of leading Pharmacovigilance for multiple clinical development programs
- Experience or high comfort level in supporting clinical programs across multiple therapeutic areas, and bridging late to early development, familiarity with gene and/or cell therapy a plus
- Ability to work with the Senior Executive Team and other external audiences such KOLs, regulatory bodies
- Solid knowledge of relevant FDA, EU, ICH guidelines, initiatives and regulations governing both safety reporting and processing for clinical trial environments
- Strong knowledge of MedDRA and common safety database
- Demonstrated leadership and technical capabilities with the ability to simultaneously manage multiple different projects
Responsibilities
- Be the leader of pharmacovigilance for Editas' clinical programs in partnership with Clinical Development, Biometrics, Clinical Operations and Regulatory Functions
- Lead the safety and risk management of the clinical studies; monitor and analyze the safety data
- Lead the development of risk management plans and associated documents to ensure that study-specific and health authority reporting requirements are met and that workflow between contract research organizations (CROs) and Editas is delineated
- Ensures timely submission of expedited safety reports to Regulatory Authorities in conjunction with Regulatory Affairs and/or Contract Service Provider
- Oversee and manage PV vendor(s) to ensure regulatory compliance and contractual obligations are met
- Reviews the safety sections of clinical documents, including protocols, annual reports, investigational brochures, and other documents
- Oversees SAE database reconciliation in collaboration with Data Management
- Ensures compliance with global regulations and ICH guidelines to meet all drug safety and pharmacovigilance reporting requirements
- Oversee preparation, development, implementation and maintenance of company SOPS and policies relating to pharmacovigilance and risk management to ensure compliance with ICH guidelines and applicable regulatory requirements
- Knowledge of current US and international regulatory requirements; Maintain current with applicable PV global regulations, and industry guidelines. Responsible for all processes and operating procedures to ensure compliance with appropriate regulations and quality standards
- Serve as the Pharmacovigilance subject matter expert for internal audits and FDA and global regulatory inspections and remediate any pharmacovigilance deficiencies found during regulatory or internal audits. Identify and follow-up on corrective action plans arising from audits and inspections
- Implements PV quality management system including the identification and authoring of required procedural documents
- Collect, analyze metric reports related to ICSRs, aggregate reports to ensure the systems and processes are compliant with the study specific plans, SOP and PV regulations
- Author, review and approve SOPs as required
- Escalate critical and major PV gaps to the management to ensure appropriate action
- Support and participate in PV training of employees as needed
- Demonstrated experience in communicating across several cross functional groups managing business process outsourcing vendors and relationships
Editas Medicine stands out as a leader in the field of genomic medicine, leveraging the potential of CRISPR gene editing technology to develop treatments for serious diseases. The company fosters a vibrant culture, encouraging collaboration and resilience among its team of 'Editors', and is committed to manufacturing and commercializing durable, precision genomic medicines. With a robust pipeline of treatments in development, Editas Medicine is not only repairing broken genes but also shaping the future of medicine.
Company Stage
IPO
Total Funding
$884.6M
Headquarters
Cambridge, Massachusetts
Founded
2013
Growth & Insights
Headcount
6 month growth
↑ 11%1 year growth
↑ 25%2 year growth
↑ 11%INACTIVE